In LSD1-knockdown CD133+ cells, both oxaliplatin and 5-FU performed extremely well in breaking down all stemness characteristics of CD133+ cells either in vitro or in vivo: silencing of LSD1 gene effectively inhibited the viability, colony formation, and invasion of colon cancer cells. This evidence concerns the gene KDM1A and colonic neoplasm.